Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study to Describe the Safety and Efficacy of Ceftaroline Fosamil in Elderly Subjects With Community-Acquired Bacterial Pneumonia

NCT01666743 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT01666743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01666743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study to Describe the Safety and Efficacy of Ceftaroline Fosamil in Elderly Subjects With Community-Acquired Bacterial Pneumonia
Lead sponsor
Forest Laboratories
Phase
Phase 4
Overall status
Withdrawn
Start date
November 30, 2012
Completion date
March 31, 2014
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

community-acquired bacterial pneumonia (cabp)